ArticlePloS one2018

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.

Ulrika Wendel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.